Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa open-label multicenter study of MN-08 tablets in adults with hypertension
CTR20234198Phase 2Active
- Sponsor
- Guangzhou Magpie Pharmaceutical
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitronaphthazine in hypertension (HTN), essential hypertension, sponsored by Guangzhou Magpie Pharmaceutical. Started Apr 2024; status: active.
02
Drugs
nitronaphthazine
03
Conditions
hypertension (HTN)essential hypertension
Beyond the preview
Go deeper on CTR20234198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20234198.